|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2005-6-30
|
|
pubmed:abstractText |
Severe acute respiratory syndrome (SARS) is a new infectious disease caused by the SARS virus. Current first-line treatments are experimental, and their effectiveness remains open to question. For more effective treatment and prevention of SARS, human SARS hyperimmune globulins for intravenous (IV) injection were purified in this study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0041-1132
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1160-4
|
|
pubmed:meshHeading |
pubmed-meshheading:15987362-Antibodies, Viral,
pubmed-meshheading:15987362-Convalescence,
pubmed-meshheading:15987362-Dimerization,
pubmed-meshheading:15987362-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15987362-Fluorescent Antibody Technique, Indirect,
pubmed-meshheading:15987362-Globulins,
pubmed-meshheading:15987362-Humans,
pubmed-meshheading:15987362-Injections, Intravenous,
pubmed-meshheading:15987362-Neutralization Tests,
pubmed-meshheading:15987362-Plasma,
pubmed-meshheading:15987362-SARS Virus,
pubmed-meshheading:15987362-Severe Acute Respiratory Syndrome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma.
|
|
pubmed:affiliation |
Shenzhen Weiwu Guangming Biological Products Co. Ltd., Guangdong, PR China.
|
|
pubmed:publicationType |
Journal Article
|
